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ABSTRACT 
 
 The protozoan parasite Giardia intestinalis is traditionally viewed as a harmful agent of 
diarrheal disease in humans, and is the target of prevention and treatment efforts around the 
world. However, most cases of G. intestinalis are asymptomatic, and prevalence rates of greater 
than 80% in several human populations without adverse effects raise the possibility that this 
microeukaryote could be a commensal member of the human gut microbiome. The Giardia 
intestinalis species has been divided into eight genetic assemblages, and some research suggests 
particular assemblages may be more pathogenic than others. In addition, research into the 
presence and assemblage diversity of G. intestinalis in traditional and hunter-gatherer societies 
can provide insight on the conditions under which this microeukaryote may be commensal in 
humans, as the gut microbiomes of these individuals have not been affected by industrialized 
practices that have historically depleted microbial diversity in the human gut. 
This thesis addresses this relatively underexplored area of research by attempting to 
determine the G. intestinalis assemblages present in asymptomatic hunter-gatherers from Peru 
and individuals from a traditional community of Burkina Faso. A hybrid approach consisting of 
targeted amplification of the glutamate dehydrogenase (gdh) gene and next-generation 
sequencing using the Illumina MiSeq was developed, and the presence of G. intestinalis was 
confirmed in the hunter-gatherer population of Peru. While poor data quality and probable 
database bias precluded a confident declaration of the assemblage, we may have identified a 
novel subassemblage of Giardia intestinalis in one individual from the Peruvian Amazon. This 
suggests that hunter-gatherer populations may harbor a greater diversity of assemblages in a 
commensal state.
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CHAPTER 1 
 
INTRODUCTION 
 
 
This study aims to fill the gap in research on natural Giardia intestinalis assemblage 
variation in humans by exploring the prevalence and genetic diversity of G. intestinalis in a 
hunter-gatherer population of Peru and a traditional community in the West African country of 
Burkina Faso. To our knowledge, only five studies in the last decade have assessed G. 
intestinalis assemblage diversity among traditional peoples, and this is the first study to assess 
the genetic diversity of G. intestinalis in hunter-gatherers of South America. High prevalence of 
asymptomatic G. intestinalis has been previously found in Peru (85% in a periurban community 
south of Lima [1] and 29% in Amazonian hunter-gatherers [2]) and Burkina Faso (31.6% in the 
Centre-Ouest region [3]), suggesting that Giardia-host relationships are complex, and not 
exclusively disease bearing. From these prior studies, we anticipate a high prevalence of Giardia 
in the two populations included in this study. Furthermore, while G. intestinalis assemblages A 
and B are most commonly found in humans, zoonotic transmission of other assemblages has 
been observed on multiple occasions [4,5,6,7,8]. Thus, it is possible the non-industrialized 
lifestyles of these traditional populations, which frequently involve close interactions with a 
variety of animals, may result in a diverse range of G. intestinalis. We aim to assess such genetic 
diversity, as well as test the hypothesis that natural variation in G. intestinalis human 
assemblages may be obscured by the bias in data from urban settings. 
 
 
What is Giardia? 
 
Taxonomy 
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Giardia is a flagellated protozoan parasite [9,10] and one of the most common parasites 
infecting humans and animals around the world today [11]. There are currently six accepted 
species of the genus Giardia, each host-specific to a wide range of animals: G. agilis 
(amphibians), G. ardeae, G. psittaci (birds), G. microti (voles), G. muris (rodents), and G. 
intestinalis (mammals). These species were distinguished based on microscopic morphology and 
molecular variations identified from DNA sequencing [9,11]. A seventh species, G. varani 
(lizards), has been proposed, but has not yet been confirmed by molecular biological 
characterizations [11]. 
Giardia intestinalis, which also goes by G. lamblia and G. duodenalis, has been 
subdivided further into eight genetic assemblages, or strains, each of which is also primarily, 
though not always, host-specific. These assemblages and their typical hosts are presented in 
Table 1. The phylogenetic relationships among these assemblages at the glutamate 
dehydrogenase (gdh) locus were assessed by Feng and Xiao (2011) using the Neighbor-Joining 
method and distance calculated by the Kimura two-parameter model. With a collection of 33 G. 
intestinalis gdh isolates obtained from the National Center for Biotechnology Information 
(NCBI) GenBank database, we recreated these phylogenetic relationships using the same tree-
building conditions as Feng and Xiao (2011) (Figure 1). 
As is evident from the table, assemblages A and B are the most versatile, infecting 
humans but also a wide range of other mammals. Allozyme analysis revealed additional sub-
structure within assemblage A into subassemblages AI and AII, which was later confirmed by 
phylogenetic analysis of sequences at the gdh locus. A third subgroup within assemblage A, 
AIII, was also identified that has significant sequence differences from subassemblages AI and 
AII at all loci examined so far [11]. It is also the rarest subassemblage of A to be found in 
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humans. Allozyme electrophoretic studies determined two subassemblages within assemblage B, 
subgroups BIII and BIV, however these groupings are not supported by DNA sequence analyses 
and thus subgrouping within assemblage B remains unclear [11]. 
 
Assemblage Typical hosts 
A Humans, nonhuman primates, domestic 
ruminants, alpacas, pigs, horses, 
domestic and wild canines, cats, ferrets, 
rodents, marsupials, other mammals 
 
B Humans, nonhuman primates, cattle, 
dogs, horses, rabbits, beavers, muskrats 
 
C Domestic and wild canines 
 
D Domestic and wild canines 
 
E Domestic ruminants, pigs 
 
F Cats 
 
G Mice, rats 
 
H Seals 
 
 
Table 1. G. intestinalis assemblages and corresponding hosts [11] 
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Figure 1. Phylogenetic relationships among assemblages of G. intestinalis at the gdh locus. The 
Neighbor-Joining method and Kimura two-parameter model were used, with 500 bootstrap 
replicates. The scale indicates substitutions per site. 
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Biology and phylogeny 
While Giardia is a eukaryote, it is a unique one, thought to be one of the most primitive 
extant eukaryotic organisms and sharing many characteristics with anaerobic prokaryotes [10]. 
For example, Giardia lacks a mitochondria, peroxisomes, and a traditional Golgi apparatus 
[9,10]. It has been suggested that Giardia spp. are pre-mitochondriate organisms, but there is 
some debate surrounding this idea due to Giardia intestinalis possessing genes considered to be 
of mitochondrial origin [12,13]. Trophozoites (the second form Giardia takes in its life cycle) of 
G. intestinalis have two identical nuclei and are polyploid, with at least four and possibly eight or 
more copies of each of five chromosomes per organism [10]. The genome of G. intestinalis is 
about 11.7 million base pairs (bp) long with 6,470 predicted protein-coding genes [14]. 
The flagella and two nuclei of Giardia, among other biological features, place the 
organism into the taxonomic order Diplomonadida. Early phylogenetic studies of the 
Diplomonadida using conserved loci determined that Giardia belongs to an early branching 
lineage [15]. While this finding led many to think Giardia was one of the more primitive 
Diplomonadida, a phylogenetic analysis of 23 morphological characters suggests that it is 
actually one of the most highly adapted [16]. Furthermore, molecular studies have shown that 
Giardia’s lack of mitochondria is not a primitive feature, reflective of divergence from an 
ancestral eukaryote before the acquisition of the organelle, but rather is a secondary evolutionary 
loss [17]. This aligns with the finding of genes considered to be of mitochondrial origin in G. 
intestinalis. However, in the majority of phylogenies in which eukaryotes are rooted using 
prokaryotic outgroups, diplomonads and their relatives in general branch out early in the 
eukaryotic tree [18]. 
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Molecular phylogenies consistently divide diplomonads into two major clades, 
Hexamitinae and Giardiinae, both of which fall under the taxonomic family Hexamitidae [18]. In 
addition, the diplomonad Octomitus sp. has been confirmed as a sister lineage to Giardia within 
Giardiinae [19]. Phylogenetic analysis based on SSU rRNA genes has also confirmed Giardiinae 
as a monophyletic group, whereas Hexamitinae form a clade with enteromonads (close relatives 
to diplomonads)[18]. 
 
Lifecycle and transmission 
 While both cysts and trophozoites can be found in the feces of infected organisms, 
Giardia cysts are responsible for transmission. The cysts are moderately chlorine tolerant and 
environmentally robust [20], able to survive for months without a host in surface water and soil 
[9]. Infection occurs when cysts are ingested through contaminated water, food, or by the fecal-
oral route, and as few as ten cysts may be sufficient to cause giardiasis infection. Ingestion of 
more than twenty-five cysts results in a 100% infection rate [21]. Excystation occurs in the small 
intestine, where each cyst releases two trophozoites, which then multiply by longitudinal binary 
fission. In the small bowel, the trophozoites are either free roaming or attach to the mucosa by a 
ventral sucking disk. Encystation occurs as the trophozoites move toward the colon, and 
ultimately cysts are excreted by the host [22]. Individuals can shed 1 x 108 to 1 x 109 cysts in 
their stool each day for several months [20]. Upon excretion, Giardia cysts are immediately able 
to infect a new host [9]. 
 The common mechanisms of Giardia transmission are person to person, animal to 
animal, zoonotic, waterborne through contaminated drinking or recreational water, and 
foodborne [9]. Waterborne transmission is likely the most common. Giardia has been found in as 
many as 80% of raw water supplies from lakes, streams, and ponds [21] and more than 130 
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waterborne giardiasis outbreaks have been reported worldwide from the early 1900s to 2004 
[9,11]. Furthermore, deficiencies in the drinking water treatment process are among the most 
frequently reported reasons for giardiasis outbreaks [9]. Farm animals excreting high numbers of 
Giardia intestinalis cysts around water supplies can be a major source of water contamination. 
The G. intestinalis assemblages that most commonly infect humans, A and B, are often reported 
for livestock species, such as goats, sheep, cattle, and pigs, around the world [9]. Additionally, 
some G. intestinalis outbreaks in North America and Spain have been linked to contamination of 
water by cysts excreted from wild animals, such as muskrats, beaver, and wild otter. Foods 
frequently consumed raw like fruit, vegetables, and shellfish, pose the greatest risk of infecting 
humans with G. intestinalis cysts [9]. Several studies have shown that G. intestinalis cysts can be 
present in oysters [23,24] and mussels [25], and others have linked food handlers or produce for 
sale to the transmission of G. intestinalis [26,27]. 
 
Epidemiology 
 Over 200 million people around the world are estimated to have acute or chronic 
giardiasis [10]. According to the Centers for Disease Control and Prevention (CDC), the illness 
infects nearly 2% of adults and 6% to 8% of children in developed countries and nearly 33% of 
people in developing countries, though rates of giardiasis approaching 90% in endemic areas 
have been reported [28]. The global prevalence of giardiasis and of the Giardia intestinalis 
parasite itself in humans varies greatly because the disease is not always reported, diagnostic 
methods used differ in sensitivity and many people are asymptomatic, especially in endemic 
areas. In the United States, G. intestinalis infection is the most common intestinal parasitic 
disease affecting humans, according to the CDC. In 2017, there were a total of 15,214 cases in 
the United States, with the incidence rate per 100,000 population ranging from 1.5 in Nevada to 
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12.2 in Alaska. By region, the Northwest had the highest incidence rate at 9.2 cases per 100,000 
population and highest percentage of cases at 25.2%. The lowest incidence rate was in the South 
at 4.4 cases per 100,000 population. In general, incidence rates were consistently higher in the 
northern states. Demographically, more males than females had giardiasis (61.6% compared to 
38.1%, respectively) and incidence rates were highest among those aged 1-4 years (11.4), 25-29 
years (6.9) and 55-59 years (6.7) [29]. 
 As in the United States, giardiasis is the most commonly reported food- and waterborne 
parasitic disease in the European Union (EU)/European Economic Area (EEA). The European 
Center for Disease Prevention and Control’s (ECDC) most recent Annual Epidemiological 
Report for giardiasis stated that in 2017, 19,437 confirmed giardiasis cases were reported with an 
incidence rate of 5.5 cases per 100,000 population. The highest incidence rates were reported in 
Belgium (17.6), Estonia (12.2), and Sweden (11.4), and the highest number of confirmed cases 
was reported by the United Kingdom at 5,225 cases, followed by Germany at 3,329 cases. 
Together, the U.K. and Germany accounted for 44% of all confirmed giardiasis cases in the 
EU/EEA for 2017. The majority (60.1%) of cases in the EU/EEA were domestically acquired 
except in three Nordic countries, where 71%-83% of cases were travel-associated [30]. 
In general, the number of confirmed giardiasis cases in Europe steadily increased from 
2013-2017. However, the ECDC notes that likely there is underreporting of cases throughout 
Eastern Europe, and one-fourth of EU Member States do not have surveillance systems for 
giardiasis. In congruence with the data from the United States, there were more cases in males 
(56%) than in females (44%) and the highest incidence rate per 100,000 population was detected 
in the age group 0-4 years, which accounted for 18% of cases with information on age. The G. 
intestinalis incidence rate decreased with age and was lowest in people aged 65 and older [30]. 
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 The prevalence of the Giardia intestinalis parasite is often quite high in developing 
countries. Western Nepal has reported one of the highest rates in Asia, at 73.4% of school-going 
children [31], and an even higher prevalence was found in Peruvian children (85%), notably 
without adverse effects [1]. Elsewhere in Asia, G. intestinalis prevalence has been 37.7% 
(Thailand), 24.9% (Malaysia), and 12.7% symptomatic and 18% asymptomatic (Bangladesh) 
[31]. Based on 33 studies published between 2002 and 2007, it has been shown that G. 
intestinalis prevalence in Asia is higher in urban than in rural areas, among poor communities, 
and slightly higher in males than in females. Multiple infections with other parasites were also 
frequently found [31]. 
There have been a limited number of population-based studies on G. intestinalis in Latin 
America, but there is nevertheless some data that reflects its pervasiveness. For instance, one 
study in Argentina detected the parasite in 33.3% of the 303 participating indigenous children 
[32] and another identified G. intestinalis in 23.8% of 366 people from Rio de Janeiro, Brazil 
[33]. Additionally, a G. intestinalis frequency of 64.8% was found in a population of children 
from Colombia [34]. 
High prevalence rates are consistently found across Africa. Out of thirty-one countries 
that reported the presence of G. intestinalis, nine had a prevalence of 40% or greater, including 
41.7% in Algerian individuals, 56% in village children of Guinea-Bissau, 41.3% in individuals 
from Kenya, 53.4% in individuals of all ages and 62.2% in children under five from Tanzania, 
and 40.7% in individuals from villages in Uganda [35].  
The immune status of the host has a major impact on the severity of giardiasis in general. 
Thus, the HIV/AIDS epidemic in African countries greatly contributes to an increased 
prevalence of giardiasis [35]. Other factors associated with a higher prevalence of G. intestinalis 
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and giardiasis in Africa include contact with animals and manure, residing in villages versus 
cities, drinking underground or tap water, and eating unwashed/raw fruit. Malnutrition is also an 
important risk factor for diarrhea and prolonged diarrhea caused by G. intestinalis, with this 
impact mainly affecting children under five [35]. While the prevalence of G. intestinalis has been 
found to be higher in men in many studies around the world, the opposite has been true in 
Ethiopia. An analysis of 393 stool samples from children attending eight rural schools in the 
Bahir Dar district of Ethiopia found that females were more frequently infected with G. 
intestinalis than males (61.1% vs. 49.5%, respectively), with the difference being statistically 
significant [36]. Other prevalence-based epidemiological studies in Ethiopia have resulted in 
similar findings: at Yirgalem Hospital in Ethiopia, results showed a statistically significant 
higher prevalence of G. intestinalis in female children (29.3%) compared to male children 
(8.1%) [37]. 
 
Implications for Human Health 
 There is no doubt that Giardia intestinalis is pathogenic in many cases. Symptoms of 
acute giardiasis commonly take the form of diarrhea, abdominal pain, malabsorption, bloating, 
fatigue, and weight loss [11,38]. Acute infection develops over a period of three weeks, peaking 
at eight days post infection. Healthy hosts typically are able to clear the infection within two to 
three weeks, but infection occasionally becomes chronic, potentially leading to the development 
of irritable bowel syndrome, chronic fatigue, and chronic diarrhea [38]. Some infections, 
especially in underweight malnourished children, can cause dramatic health impairments, 
including worsening of nutrition, growth retardation, and cognitive impairment. The worst 
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effects of G. intestinalis infection are related to damage of the absorptive small bowel mucosa, 
along with abnormal intestinal immunity [39]. 
The Centers for Disease Control and Prevention consider giardiasis to be a public health 
concern, as it is frequently diagnosed in the United States. They provide extensive information 
for the public on Giardia intestinalis and giardiasis, including illness and symptoms, diagnosis, 
treatment, risk factors, and prevention and control. The CDC also notes that giardiasis is a 
nationally notifiable disease, meaning health care providers and laboratories are required to 
report cases of the disease that they diagnose to local or state health departments. In addition, in 
2004, G. intestinalis was added to the World Health Organization’s Neglected Diseases 
Initiative. All Neglected Diseases have a common link with poverty and “exhibit a considerable 
and increasing global burden, and impair the ability of those infected to achieve their full 
potential” [40]. Particular concerns were G. intestinalis infections in children and individuals 
with AIDS, as the risk of disease complications is greater for these groups. In adding G. 
intestinalis to the Neglected Diseases Initiative, the hope was to gain more insight into the 
biology and impact of this parasite, especially through molecular methods, to generate better 
control strategies [40]. 
 While concerns over symptomatic disease caused by G. intestinalis are valid, most cases 
of this protozoan in humans are asymptomatic, and there is increasing evidence that G. 
intestinalis is a frequent component of the gut microbiome. As part of the Malnutrition and 
Enteric Disease (MAL-ED) project from November 2009 to February 2014, G. intestinalis was 
detected in two-thirds of 1,741 children across eight countries in which diarrheal disease and 
malnutrition are endemic (Bangladesh, Brazil, India, Nepal, Peru, Pakistan, South Africa, and 
Tanzania) [41]. At each of the eight study sites, the parasite was found in 37 to 95% of children 
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within the first two years of life, yet G. intestinalis was not significantly associated with diarrhea 
regardless of site or age [42]. Similarly, a separate study in Peru detected G. intestinalis in 85% 
of children, with 87% becoming reinfected, and the infection did not affect growth nor was 
associated with an increased risk of diarrhea at any age [1]. Non-diarrheal G. intestinalis 
infections have not only been highly prevalent in endemic areas, but G. intestinalis detection has 
frequently been negatively associated with diarrhea, suggesting it has a protective effect against 
diarrhea [42]. Corroborating this, quantitative nucleic-acid based diagnostics have suggested that 
higher quantities of G. intestinalis are associated with even greater reductions in diarrhea risk 
[43]. Given the ubiquity of the protozoan and its failure to show an association between infection 
and symptomatic illness in many cases, some even argue against the administration of Giardia-
specific drugs in endemic areas [44]. 
There is clearly ambiguity in the health implications of G. intestinalis for humans. Still, 
the majority of the literature on G. intestinalis focuses on it as a pathogen that should be 
controlled, recommending prevention measures such as better sanitation, hygiene, and water 
treatment. Out of 3,741 articles on Giardia published on NCBI’s PubMed database between 
1915 and 2018, the highest percentage of articles (27.5%) are on the biology of the organism 
itself, either seeking to understand more about an early diverging eukaryote, or researching the 
biological mechanisms by which G. intestinalis causes illness in humans. Articles that explore 
the presence of Giardia in various water sources or water treatment practices to eliminate it, 
along with G. intestinalis’ general prevalence in humans, constitute 22.2% of all the published 
articles. Many of the articles on prevalence explore G. intestinalis’ potential links with other 
health issues. Additionally, 11% of articles address the presence of the various genetic 
assemblages of G. intestinalis in humans, and 9% propose different treatments for G. intestinalis 
  13 
infection. As is evident from this data, research into asymptomatic cases of G. intestinalis is 
lacking. Yet, since those cases are pervasive, it raises the possibility that G. intestinalis is 
sometimes a commensal organism in the human microbiome.  
 While more research needs to be conducted, there are some hypotheses about why the 
manifestations of G. intestinalis infection vary. One is the ecological perspective, where the 
diversity and interactions of commensal microbes in the mammalian gut affect G. intestinalis 
colonization and consequent symptoms. Physiological diversity of commensal microbiota is 
crucial for overall stability of the gut ecosystem; greater diversity allows more resilience and 
flexibility of microbial responses to external stress, aiding the immune system. If this ecosystem 
is disrupted, it may impact the disease manifestation of G. intestinalis [28]. There is evidence 
that interactions between G. intestinalis and commensal microbes could contribute to variations 
in pathogenesis. In one murine study, for example, it was found that mice from one commercial 
breeding farm were less susceptible to G. intestinalis infection than were mice from another 
facility, presumably due to differences in the composition of commensal gut microbiota between 
the two groups [45]. 
 A second hypothesis for the variation in or lack of G. intestinalis symptoms is differences 
in the genetic strains, or assemblages. As assemblages A and B are the primary strains found in 
humans, their relations to symptoms of G. intestinalis infection in humans have been studied the 
most. Some research has found more severe symptoms, such as diarrhea, associated with 
assemblage B infection, compared to assemblage A [46]. A murine study determined that 
infection with G. intestinalis assemblage B caused decreased growth and mucosal 
histopathological changes in mice that matched what is seen in chronic human giardiasis [39]. In 
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addition, infection with particular subassemblages of A or B could contribute to symptom 
variation, as could infection with other assemblages of G. intestinalis in humans. 
 
Current Understanding of the G. intestinalis Genetic Assemblages in Humans 
 An analysis of over 4,000 human isolates from different geographical locations by PCR 
amplification of fecal DNA extracts demonstrates that primarily only Giardia intestinalis 
assemblages A and B are found in humans [11]. However, the distribution of these two 
assemblages in humans varies greatly. For example, out of a total of 78 positive cases of G. 
intestinalis in Ethiopian children that were able to be typed, 14 isolates (17.9%) were assemblage 
A and 64 isolates (82.1%) were assemblage B [36]. In contrast, out of 60 positive G. intestinalis 
samples from Iran, 35 isolates (58.3%) were assemblage A, 17 isolates (28.3%) were assemblage 
B, and 7 (11.6%) contained a mix of both A and B [47]. Out of the 4,000 isolates analyzed, 
assemblage B was slightly more prevalent in both developed (1,589 isolates) and developing 
(708 isolates) countries compared to assemblage A (1,096 and 482 isolates, respectively). 
However, there is no clear geographic pattern in the distribution of the assemblages; their 
distribution can vary even within the same country [11]. For example, one study in Peru 
determined 10 positive G. intestinalis isolates as assemblage A compared to 6 of assemblage B 
[48], and another Peruvian study found 6 assemblage A isolates compared to 19 assemblage B 
[5]. While these sample sizes are small, there are numerous instances of assemblages A and B 
distribution variation both within and between countries [11,49] that corroborate the inability to 
make any conclusions about a pattern of distribution. 
 There is, however, a pattern in the host distribution of assemblages A and B, as well as 
potential host and geographic patterns in the distribution of the subassemblages AI, AII, AIII, 
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BIII, and BIV. An analysis by Sprong et al. (2009) of 3,812 G. intestinalis sequences extracted 
from a variety of sources found that humans are the major source of assemblage B; 56% of the 
sequences from humans were assemblage B, compared to less than 5% of the sequences from 
cats and livestock, and less than 10% of the sequences from dogs. Conversely, assemblage A had 
a fairly even distribution among companion animals, livestock, humans, and wildlife [50]. This 
pattern could relate to why assemblage B was found to be slightly more prevalent among humans 
globally, and also why assemblage B often causes more severe symptoms for humans. 
 Sprong et al. (2009) also examined distributions of the subassemblages of A and B, 
identifying some clear patterns. Out of 594 human cases of G. intestinalis assemblage A, the 
majority (75%) were of the subassemblage AII, and 25% were AI. In contrast, in all other hosts 
of assemblage A—companion animals, livestock, and wildlife—subassemblage AI was 
significantly more prevalent than the other subassemblages. None of the G. intestinalis cases in 
humans, dogs, goats, sheep, and pigs were subassemblage AIII, and its presence is 
overwhelmingly in wildlife, occurring in 52% of assemblage A cases in that source. There was a 
similar pattern between humans and other animals in the distribution of the subassemblages of 
assemblage B. Of 787 human cases of assemblage B, 56% were BIII, whereas the domestic dog 
and wildlife cases of assemblage B were largely subassemblage BIV (73% and 94% of cases, 
respectively) [50]. 
 From the human cases of G. intestinalis assemblages A and B described above, some 
geographic patterns emerged in the distribution of the subassemblages [50]. Subassemblage AI 
was more prevalent in Asia and Australia (60% and 69% of cases, respectively) than AII, and 
AII was more prevalent than AI in all other parts of the world. However, the distribution of the 
two subassemblages was closer to 50% in the Americas than elsewhere in the world, suggesting 
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more genetic diversity of assemblage A in the Americas. Subassemblage BIII was noticeably 
more prevalent in Africa, Asia, the Middle East, and Central/South America compared to 
subassemblage BIV, and in North America the opposite was true, with BIV comprising 86% of 
the assemblage B cases in humans. In Australia and Europe, subassemblages BIII and BIV were 
almost evenly distributed, with a BIII to BIV distribution of 52% to 48% in Australia and 49% to 
51% in Europe [50]. 
Mixed infections of assemblages A and B together can occur, as well. Of the 4,000 
human isolates around the world mentioned above, 23 isolates in developed countries and 84 
isolates in developing countries were mixed infections of A and B [11]. Additionally, other G. 
intestinalis assemblages have occasionally been detected in human samples. Of 1,658 G. 
intestinalis isolates extracted from European individuals, two were assemblage C, and there were 
four each of assemblages D, E, and F [50]. Humans were also found to be infected with 
assemblage C in Thailand [6], Brazil [51], and Egypt [7], assemblage E in Egypt [52,53], Brazil 
[8], and Australia [54], and assemblage F in Ethiopia [4] and Slovakia [55]. Furthermore, the 
seven instances of assemblage F in Ethiopia were in fact mixed G. intestinalis infections with 
assemblage A [4], and one case of assemblage E in Egypt was also a mixed infection with 
assemblage B [52]. While mixed infections of assemblages A and B are not surprising, these 
other combinations of mixed G. intestinalis assemblages in humans are unique and intriguing. 
 
The Gaps in Giardia Research 
Research on the potential of Giardia intestinalis to be a commensal member of the 
human gut microbiome is lacking, and more studies on asymptomatic cases in humans could 
provide clarity on that possibility. Furthermore, research into the presence of G. intestinalis in 
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more traditional and hunter-gatherer societies can be particularly enlightening, as the gut 
microbiomes of these individuals have not been affected by industrialized diets, sanitation 
practices, medicines, and other practices of industrialization. The gut microbiomes of traditional 
peoples provide unique representations of human guts without much modern interference. Thus, 
if G. intestinalis is detected, it provides strong evidence for this organism being a natural, 
commensal member. 
 Few studies have explored the presence or assemblage diversity of G. intestinalis in 
hunter-gatherers. Assemblage information in particular is crucial for understanding 
asymptomatic cases of G. intestinalis, as variation in assemblages could explain the differing 
human responses to this microeukaryote. Under the search term “Giardia” and filter “Humans” 
on PubMed, nine studies were published between 2010 and 2020 on G. intestinalis in traditional 
or hunter-gatherer populations. The studies were performed in such locations as the subtropical 
Atlantic Forest of Argentina [32], the Colombian Amazon Basin [34], Peninsular and East 
Malaysia [56,57,58], Northern Thailand [59], Central Taiwan [60], Northwestern Ecuador [61], 
and the Peruvian Amazon [2]. While the studies are fairly numerous, just three included hunter-
gatherer communities [2,57,58] and only one examined the prevalence of G. intestinalis in 
hunter-gatherers of South America [2]. Furthermore, over half of the nine studies took place in 
Asia. This is in accordance with the noticeable gap in G. intestinalis research in South America 
in general. 
Of the nine studies, five assessed assemblage diversity of G. intestinalis [34,56,57,59,60], 
with four of those studies located in Asia and nearly all study participants being children. Only 
assemblages A and B were detected in all studies. The aboriginal community in Taiwan had the 
lowest overall prevalence of G. intestinalis at 3.83% and was also the only community to not 
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harbor assemblage B. All positive cases of G. intestinalis were assemblage A, specifically 
subassemblage AII [60]. All other communities from Asia had an even or nearly even 
distribution of assemblages A and B, however, distributions of the subassemblages differed by 
location, even within the same study. In Thailand, tribes in the Hod District had slightly more 
genetic diversity of G. intestinalis than those from the Mae-Chaem District, with subassemblages 
AII, BIII, and BIV detected compared to just AII and BIV, respectively. Subassemblage BIV 
was also more common in tribes from the Hod District, present in 60% of positive G. intestinalis 
samples, whereas AII was most prevalent in individuals from Mae-Chaem, identified in 77.8% of 
positive samples [59]. All cases of G. intestinalis assemblage A in Orang Asli tribal children in 
Malaysia were identified as subassemblage AII, whereas assemblage B consisted of nucleotide 
variation too high to enable subtyping. There were also 43 cases of mixed assemblage G. 
intestinalis present in the Orang Asli children [57]. 
The highest prevalence of G. intestinalis in these traditional societies was found in 
children from the Colombian Amazon, with 64.8% of screened samples being positive [34]. 
Additionally, there was significant genetic diversity within these cases, with subassemblages AI, 
AII, BIII, and BIV all detected. The frequency of each of these subassemblages depended on 
which gene was targeted in the analysis. According to analysis of the gdh gene, subassemblage 
AI was most common (61%), followed by subassemblage BIII (32%). In contrast, the tpi gene 
determined subassemblage BIII to be more common (59.6%) compared to AI (19.1%) [34]. 
While the study on G. intestinalis in hunter-gatherers of Peru did not examine assemblage 
diversity, overall prevalence of the organism was 29%. G. intestinalis was the second most 
common intestinal parasite in these Peruvians next to Blastocystis hominis (40%) [2]. 
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Not only is there a lack in data on G. intestinalis assemblage diversity in traditional 
populations, but there is disproportionate reporting of assemblages around the world. This is 
reflected in Figure 2, which is our representation of the global assemblage data collected and 
made publicly available by Garcia-R. et al. (2017). The researchers extracted 4,348 records on G. 
intestinalis assemblages detected in humans and animals from 64 countries, and discovered that 
assemblages A and B represent more than 60% of the reported data worldwide [62], which is 
evident from the pie charts in Figure 2. Furthermore, the majority of available data were 
retrieved from China, Australia, and Brazil [62]. In fact, data from China comprises 72% of the 
total data from Asia and data from Brazil is 57% of all the data from South America. Excluding 
Brazil, data from South America comprises just 5.6% of the global data (13% with Brazil). 
Additionally, only 6.1% of the world data is from Africa, and a mere 0.9% is from Central 
America. The obvious paucity of data from Central America, most of South America, and nearly 
all of Africa reflects the bias in published G. intestinalis research, and is likely contributing to 
primarily assemblages A and B being reported. 
Considering assemblages other than A and B have been reported in humans, but only in 
European or urban communities, and given the significant amount of missing data from 
developing countries in general and traditional or hunter-gatherer societies in particular, 
questions arise as to what kind of G. intestinalis assemblage variation may be present in these 
populations. If found, this information may shed light on the conditions under which G. 
intestinalis can be commensal in humans. 
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Figure 2. Global distribution of G. intestinalis assemblages from data presented in Garcia-R. et 
al. (2017). This data represents G. intestinalis isolates extracted from both humans and animals. 
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CHAPTER 2 
BACKGROUND – FROM MICROBIOME TO EUKARYOME 
 
The Human Gut Microbiome 
 Our bodies are not entirely human. While humans consist of 0.3 x 1013 nucleated cells, 
we are also home to approximately 3.8 x 1013 microbial cells that primarily inhabit four regions 
of the body: skin, oral, vaginal, and gut [63]. These numbers, in effect, estimate our cellular 
composition as only 10% human. Joshua Lederberg is credited with first suggesting the concept 
of the human microbiome, defining the phrase to “signify the ecological community of 
commensal, symbiotic, and pathogenic microorganisms that literally share our body space” [64]. 
Now, “microbiome” is commonly used interchangeably to refer to all of the microbiota in a 
given habitat, as well as the collective genome of all those microbiota. 
 The most densely colonized body site is the gut, with approximately 99% of the 3.8 x 
1013 microbial cells residing in the colon [65]. Due to its abundance of microorganisms and their 
associations with a variety of disorders, including immune and metabolically driven diseases, the 
gut microbiome has been the most studied of the microbial regions. As of 2018, a total of 15,335 
publications out of almost 40,000 indexed under the search term “microbiome” in PubMed 
pertained to research on the gut microbiome, specifically. This was the largest category of 
microbiome publications, with the other major aspects of microbiome research being host 
processes (13,805 publications) and diet (5,709 publications) [66]. 
 
Composition and function 
 Microorganisms are found throughout the human gastrointestinal tract, with variations in 
type, density, and metabolic activity of microbiota residing in the stomach, small intestine, and 
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colon. Contents of the small intestine reside there for a relatively short period of time, with a 
median time of 255 minutes, which prevents microorganisms from reaching a high density [65]. 
In contrast, the long transit time in the colon of about 35 hours [67] allows more proliferation of 
microorganisms. In general, the microbial composition in the small intestine is also more 
variable among individuals and over time compared to the fecal microbiota [65]. Furthermore, 
the diversity of bacterial genera is greatest in the colon, with 34 major genera identified in the 
colon compared to 14 genera in the small intestine and eight genera in the stomach [65]. Only 
three genera that are found in the stomach (Gemella, Rothia, Helicobacter) are not shared in the 
colon, and seven genera that reside in the small intestine (Megasphaera, Brevibacillus, 
Veillonella, Gemella, Leptotrichia, Neisseria, Haemophilus) are not in the colon. Among all 
three areas of the gastrointestinal tract, just five major genera are shared (Streptococcus, 
Porphyromonas, Prevotella, Atopobium, Fusobacterium) [65]. It should be stressed that these are 
only the major bacterial genera, and estimations of the true number of microbial species present 
in the colon or feces vary significantly, although the count is undoubtedly much higher compared 
to other microbial habitats. 
 While the majority of microbial species in the gut are bacteria, the gut microbiome also 
consists of archaea, eukaryotes, and viruses. Methanobrevibacter smithii and Methanosphaera 
stadtmanae are two primary species of archaea found in the gut, both of which aid in the 
formation of methane [65]. Intestinal fungi, referred to as gut mycobiome, are the most 
prominent eukaryotic members [65]. Although not well studied compared to the prokaryotes, 
some attempts at characterizing intestinal fungi have been made. For example, an analysis of 
fecal samples from 98 healthy individuals revealed 66 fungal genera and an estimated 184 
species. Saccharomyces, Candida, and Cladosporium were the most prevalent genera, found in 
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89%, 57%, and 42% of samples, respectively [68]. Even less studied than intestinal fungi are 
protozoan microeukaryotes, which are also important members of the microbial community. As 
more research on microeukaryotes emerges, it is becoming more evident that both fungi and 
protozoa play important ecological and health-related roles in the gut microbiome [69]. Viruses 
are not considered to be living organisms, but nevertheless several thousand bacteriophage 
genomes have been detected in human fecal samples [70]. 
 One important function of gut microbiota is to protect the host from pathogens and 
unwanted colonization, in part by supporting the immune system. However in addition to this, 
microbiota also provide enzymes that expand the metabolic capacity of the host, assisting in the 
breakdown of dietary components that the host cannot use, such as carbohydrates, proteins, and 
secondary plant metabolites [66]. A mutualistic relationship exists between the microbiome and 
the host, with immune and metabolic receptors sensing and processing microbial signals. This 
relationship has led to the idea of the microbiome as a “forgotten organ” that coevolved with the 
mammalian host [66]. 
 The gut microbiome has been divided into two key sections: the core microbiome and the 
variable microbiome. The microbiomes of different individuals share a high proportion of gene 
functions, namely for metabolic activities; these ubiquitous functions represent the core 
microbiome. In contrast, there are functions that are present in some individuals but not in others, 
creating the variable microbiome [65]. Several studies of unrelated, healthy adults have revealed 
substantial diversity in their gut communities [71,72,73]. Among family members, the human gut 
microbiome is generally shared, but each person’s gut microbial community still varies in the 
specific bacterial lineages present [74]. 
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 There are still many gaps in our understanding of the human gut microbiome, including 
the composition, exact mechanisms underlying microbe-microbe or microbe-host interactions, 
and the role of various microorganisms in health and disease. One central question is whether 
microbiome alterations are the cause or consequence of pathologies [66]. 
 
The Anthropology of the Microbiome 
 Microorganisms are part of us as human beings, and the microbial ecosystem likely 
coevolved with us [71,72]. There is substantial interindividual variation in the microbiomes of 
human populations [66]; therefore, the microbiome is a source of human diversity and should be 
considered in anthropological studies surrounding human variation both within and between 
populations. 
 The diversity of the human gut microbiome is exemplified by the examination of fecal 
samples from individuals of different ages and from different geographic regions. An analysis of 
fecal samples from 531 individuals comprised of healthy children and adults from the Amazonas 
of Venezuela, rural Malawi, and U.S. metropolitan areas produced some significant findings 
regarding variation in gut composition [73]. There were some similarities in the gut microbiomes 
of individuals from all three regions. For example, the functional maturation of the gut microbial 
community to an adult-like configuration within the first three years of life was the same in all 
three populations. In addition, interpersonal variation was greater among children than among 
adults regardless of geographic location, intrapersonal variation decreased with age, and bacterial 
diversity increased with age in all populations. However, differences in the composition of fecal 
microbiota were detected between individuals from the different countries as well, especially 
between the U.S. and the Malawian and Amerindian gut communities. Of the three populations, 
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the fecal microbiota of U.S. adults was the least diverse, and there were distinct microbial 
community signatures for Western (U.S.) and non-Western individuals. Out of 92 species-level 
Operational Taxonomic Units (OTUs), 73 were over-represented in non-Western adults. 
Interestingly, the distinctions were less in infants: only 28 OTUs discriminated U.S. and non-
U.S. infants [73]. These findings suggest that a Western lifestyle significantly alters the microbe 
composition of the gut and it does so systematically.  
 An important area of anthropological study is understanding how factors such as age, 
environment, and cultural traditions shape us as human beings. These factors directly affect the 
composition of the gut microbiome, which in turn influences human physical, mental, and 
pathophysiological states. Thus, examination into the variations in gut microbiomes between 
individuals and populations, especially between industrialized and non-industrialized societies, 
can answer a variety of questions surrounding the source of diverse human conditions. 
 
The Gut Microbiome and the “Hygiene Hypothesis” 
 In 1989, David P. Strachan introduced a concept that became known as the “hygiene 
hypothesis”. In a longitudinal epidemiological study of hay fever and atopic diseases among 
British children, Strachan noted associations between hay fever and family size and position in 
the household in childhood. Hay fever was inversely related to family size in that larger families 
had a lower prevalence of hay fever. Additionally, eczema in the first year of life was 
independently related to the number of older children in the household. These findings suggested 
that allergic diseases were prevented by infection in early childhood, acquired from unhygienic 
contact with older siblings [75]. Strachan deduced that increased standards of hygiene, as well as 
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declining family sizes, have reduced early childhood infections and consequently increased the 
prevalence of allergic diseases [75]. 
 Since Strachan’s initial proposal, there have been some critiques to the hygiene 
hypothesis. It is argued that the increase in allergic disorders does not correlate with the decrease 
in pathogenic infections and cannot entirely be explained by changes in domestic hygiene. What 
has been suggested instead is the “microbial exposure” or “microbial deprivation” hypothesis, 
where decreased exposure to certain microbial species has inhibited the development of 
immunoregulatory mechanisms [76]. Humans co-evolved with and learned to tolerate numerous 
harmless organisms, such as bacteria, archaea, fungi, and protozoa, that occupied the natural 
environment and entered the body on a regular basis. Isolated hunter-gatherers and other 
traditional populations have been able to retain this tolerance and benefit from the 
immunoregulation microbes provide [77], while industrialization has depleted microbial 
colonization in many other human populations. Several changes in recent decades in addition to 
hygiene practices—in food and water quality and general public health—likely altered human 
exposure to commensal microorganisms and components of microbes such as bacterial 
endotoxins [76]. In the attempt to reduce exposure to pathogens, humans have unintentionally 
enabled greater expression of atopy, or the genetic predisposition to develop allergic diseases, 
such as asthma, due to a heightened inflammatory response to common allergens [78]. This is 
especially true in Westernized countries, where a more sterile lifestyle prevents exposure to a 
variety of microbes that could serve protective functions. Both the incidence and prevalence of 
atopy is usually much lower in most developing countries [76]. The International Study of 
Asthma and Allergies in Childhood (ISAAC) showed an asthma prevalence of 2-3% in 
developing countries and 20-40% in developed countries in self-reporting 13-14 year-olds [79]. 
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 Evidence in support of the “microbial exposure” concept can be found in many areas, 
including place of residence, food-borne and gastrointestinal disease, gut flora, and intestinal 
parasites. Some studies have noted that living on a farm can have a protective effect against 
allergic diseases, even in comparison to other rural environments. For example, over a 16-year 
period, a statistically significant increase in the incidence and severity of hay fever and asthma 
was seen in rural children with no contact with agriculture, while children on farms had less 
atopic disease and lower levels of seroprevalence to a wide range of allergens [76]. The specific 
exposure responsible for this difference is uncertain, but some scholars are exploring bacterial 
endotoxins as the possible protective factor [76]. 
 Bacterial flora in the gut can play an important protective role against atopy. In a study of 
allergic versus nonallergic Estonian and Swedish children, Bjorksten et al. (1999) discovered that 
allergic children in both countries were less often colonized with lactobacilli and bifidobacteria 
compared to the nonallergic children. In addition, the allergic children had both higher counts 
and proportions of aerobic microorganisms, particularly coliforms and Staphylococcus aureus 
[80]. 
 While the term “parasite” carries a negative connotation, there is research to suggest 
some intestinal parasites can be protective against other afflictions, such as atopy. A case-control 
study of Italian males found that men with atopy had significantly lower serum levels of 
antibodies to the parasite Toxoplasma gondii, as well as the bacteria Helicobacter pylori, than the 
non-atopic controls. Similarly, among the 245 participants exposed to at least two of the three 
infections studied (T. gondii, H. pylori, and hepatitis A virus), allergic asthma and allergic 
rhinitis were rare, present in only one individual (0.4%) and sixteen men (7%), respectively [81]. 
T. gondii, H. pylori, and hepatitis A virus are all transmitted through the fecal-oral or food-borne 
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route, thus the investigators of the Italian study concluded that the increased prevalence of 
allergic asthma and rhinitis in developed countries has been facilitated by greater hygiene and a 
semi-sterile diet [81]. These Western practices limit exposure to commensal or pathogenic 
microorganisms and influence their overall pattern in the gut. 
 Other parasites industrialized populations are less exposed to are helminths, which could 
also contribute to the atopy epidemic in the Western world. Several studies on helminths have 
noted their strong immunomodulatory effects [82], as well as their associations with lower 
prevalence of allergic diseases, particularly when infection is heavy or chronic [76]. An analysis 
of individuals from Ethiopia who self-reported wheezing found that the risk of wheeze was 
independently reduced by hookworm infection, and this seemed to be related to the intensity of 
infection. This suggests that parasitic infection by certain helminths might prevent asthma 
symptoms in atopic individuals [83]. 
 T. gondii and hookworm are eukaryotes, and while it is unclear whether these two 
parasites in particular are regular residents of the healthy human gut microbiome, many 
eukaryotes are. Additionally, these other eukaryotes are often not pathogenic, but commensal or 
beneficial for the health of the host. 
 
The “Eukaryome” 
 Many uni- and multicellular eukaryotes (protists and helminths) are thought of as 
“parasites”, which implies that they are alien to the human gut. However, microbial eukaryotes 
(microeukaryotes) are common inhabitants of the human gut microbiome worldwide [84]. While 
the eukaryotic component of the gut microbiome—which has been called the “eukaryome” 
[85]—has been understudied in comparison to bacterial microbes, it is becoming increasingly 
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clear that microeukaryotes play important roles in the ecology of the human gut microbiome and 
in human health [69,84,85]. 
 Eukaryotes, which are defined by the presence of nuclei, are most visibly represented by 
animals, plants, and fungi, but there are in fact more than 70 lineages of eukaryotes, most of 
which are microbial [84]. In the healthy human gut, fungi (such as filamentous fungi and yeasts) 
are the most prominent members [66,84], but the eukaryome also includes protozoans and 
helminths [69]. 
Historically, microeukaryotes have been studied for their parasitic or pathogenic 
relationships with the host. While some intestinal protists and helminths are in fact pathogenic, 
such as Cryptosporidium sp., Entamoeba histolytica, and Ascaris lumbricoides, most of the 
eukaryome is commensal or beneficial [69,85,84]. There are some microeukaryotes that are 
probiotics and thus benefit the host. A well-known example is the yeast Saccharomyces 
boulardii, which was an effective treatment for cholera and is now a general cure for diarrhea 
[84]. Others are occasionally beneficial, depending on the context, such as the example 
previously mentioned of the role of hookworm infection in reducing asthma and other allergic 
diseases [83]. Still other microeukaryotes are neither beneficial nor harmful (commensals), 
including Pentatrichomonas and Entamoeba dispar [84], or are pathogenic in some individuals 
and commensal in others. 
 One intriguing example of a potentially commensal protist that has frequently been 
associated with gastrointestinal disease in the literature is Blastocystis sp. [69,85]. This 
microeukaryote is quite common in individuals around the world, colonizing the intestine of 0.5 
to 30% of people in industrialized countries and 30 to 100% of those in non-industrialized 
societies [69]. While the presence of Blastocystis in both healthy and diseased individuals creates 
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controversy over its role in human health, it clearly has associations with the bacterial ecology of 
the gut. Its presence is linked to a significant increase in bacterial alpha diversity [86] and to 
compositional shifts in abundant bacterial taxa [87]. One possible explanation for these effects of 
Blastocystis applies the idea of food web theory. It has been suggested that without the presence 
of Blastocystis in the gut microbiome, one strong bacteria can dominate the community, 
monopolizing nutrients and limiting species richness. Blastocystis may serve a predatory role on 
abundant bacterial taxa, thus lowering competition for resources and allowing more bacterial 
evenness to flourish [69]. More studies are needed to test this theory. Blastocystis may positively 
influence the host immune system as well by stimulating mucus production, which relieves 
symptoms of colitis and generally improves gut health. This ability to maintain a healthy mucus 
layer in the intestine is one potential reason why Blastocystis is more common in healthy 
individuals [85]. 
 Just as there is substantial interindividual variation in the gut microbiomes of humans in 
general, the composition of the eukaryome varies among individuals as well, as do host 
responses to colonization by individual microeukaryotes, especially parasites. This results in 
some people experiencing disease while others are asymptomatic in the presence of common 
eukaryotic organisms. There are many factors behind the differences in both eukaryome 
composition and manifestations of pathology. One relates to environment and lifestyle: isolated 
communities, such as hunter-gatherers, have retained tolerance to certain infections by helminths 
and gut parasites from our evolutionary past [77]. Other major factors include host immune 
response, prior exposure to the organism, host genetics, host nutritional status, and co-infection 
with multiple parasites. The variations in bacterial and archaeal residents with which parasites 
and other microeukaryotes interact also likely contribute to disparate responses to them by hosts 
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[84]. Furthermore, disruptions to an individual’s normal gut microbial community often causes 
disease symptoms, similar to how symptoms from Clostridioides difficile (formerly Clostridium 
difficile [88]) result from changes in the gut microbial community. Some microeukaryotes that 
are present in the microbial communities of healthy individuals cause disease symptoms when 
their numbers increase, such as the flagellate Chilomastix and the fungus Candida albicans. 
Additionally, diseases such as Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease 
(IBD) are known to be caused by Blastocystis and fungi, respectively, when complex changes in 
the microbiome occur. However, it is unclear whether these changes are restricted to the site of 
disease or occur as systemic changes in the overall gut [84]. 
 The most notable difference in composition of the human gut microbiome, including the 
eukaryome, exists between individuals from industrialized versus non-industrialized societies. 
The diversity of microeukaryotes in the gut is significantly lower in industrialized populations 
[69,85], due to several differences in lifestyle and environment that have altered the routes of 
dispersal of many protozoans [69]. Industrialized societies have experienced improved personal 
hygiene and increased food and water sanitation, in addition to targeted removal of particular 
protozoans. Because many eukaryotes in the human gut have been labeled as parasites and thus 
assumed to have negative effects on the host, Western doctors almost always remove them, even 
in asymptomatic individuals [85]. Furthermore, copious antibiotic use in industrialized 
populations can have negative consequences for not only the beneficial bacteria in the gut, but 
for the microeukaryotes as well. For example, the modifications bacteria experience as a result of 
antibiotics can in turn influence the colonization and survival of gut fungi [69]. 
 High diversity of the gut microbiome in general is associated with healthy individuals 
and fewer cases of autoimmune and inflammatory disease [77]. Thus, it is likely that greater 
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diversity of the eukaryome is also beneficial for host health, as gut microeukaryotes can 
encourage the diversity of the microbiome overall [85], as in the Blastocystis example above. 
The industrialized gut’s paucity in microeukaryotes from the practices previously mentioned can 
have a “domino effect” on the rest of the microbial community and consequently on host 
immunity [69], explaining the abundance of autoimmune diseases and more frequent 
symptomatic responses to protozoan colonization in industrialized populations compared to more 
traditional societies. 
 The eukaryome has been studied less than the bacterial microbes in the human gut and as 
such it is far less understood. In particular, more research is needed to better understand how 
microeukaryotes interact with bacteria and other members of the gut microbiome, given the 
variation in pathology manifestation that can occur, and the likely important ecological roles of 
eukaryotes in the gut. The eukaryome has historically been viewed as inherently harmful, yet 
most intestinal microeukaryotes are commensal or beneficial, and ignoring those positive roles 
may actually be hurting human health [85]. Examining the gut microbiomes—and their 
eukaryotic components in particular—of healthy individuals from non-industrialized, traditional 
societies, will be important for a broader understanding of what constitutes a normal eukaryotic 
resident in the microbiome.  
Our perceptions of certain intestinal parasites may especially change. Previously 
mentioned were some intestinal parasites (Toxoplasma gondii and helminths) that are 
occasionally beneficial for their host, protecting against atopy. In addition, Blastocystis is a 
eukaryote that, while generally very common worldwide, is less prevalent in industrialized 
populations and also more likely to cause disease symptoms in that demographic compared to 
traditional societies. Yet, there is strong evidence to suggest it is an important ecological player 
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in the gut microbiome [69]. Another intestinal parasite that is common around the world—in 
fact, it is the most common intestinal parasite—is Giardia intestinalis (also known as G. 
duodenalis and G. lamblia). Similar to Blastocystis, it is more prevalent in non-industrialized 
societies and is also frequently asymptomatic [39,42], though it can cause diarrheal disease [38]. 
Given that there are other intestinal parasites that can be commensal or beneficial, and 
considering the similarities G. intestinalis shares with Blastocystis, it is reasonable to suspect that 
Giardia is more than a pathogen. 
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
 
Samples  
 Human fecal samples previously collected from two geographically distinct populations 
were used for the purposes of this study. These consist of the Matses (N=19), a hunter-gatherer 
population from the Amazon jungle of Peru, and traditional individuals from the West African 
country of Burkina Faso (N=46). The Matses population (denoted by SM) consisted of 7 males 
and 12 females, with an age range of 2 to 52 years; the Burkina Faso population (denoted by 
TM) comprised 26 males and 20 females, aged between 5 and 87 years. 
 DNA was previously extracted from the fecal samples using the Qiagen AllPrep 
PowerViral DNA/RNA kit, following manufacturer’s protocol. For the purposes of this study, 
genomic DNA from two strains of Giardia intestinalis, WB clone C6 and Be-1, was obtained 
from BEI Resources. This DNA was used for PCR optimization and as a positive control. 
 
Targeted amplification 
 There is a great diversity of bacteria and microeukaryotes in the human gut, many of 
which are present in high abundance, which complicates molecular methods used for 
characterizing Giardia. Consider that a Giardia intestinalis genome is roughly 11.7 Mb [39,42] 
in size while a bacterial genome averages 3.6 Mb [89]. Even being conservative, it takes less 
than five bacterial genomes, on average, to equal the G. intestinalis genome size; however, in all 
likelihood, given the billions of bacterial cells in the human gut [65], such cells are likely to 
outnumber G. intestinalis cells by the millions, although there has yet to be accurate assessments 
for the latter. Shotgun metagenomics methods will sample genomes at random, based on the 
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relative frequencies/genome size in the DNA extract, and thus capturing G. intestinalis variation 
would require a depth of sequencing that is unreasonable by current methods. Therefore, a 
targeted approach to detecting G. intestinalis in extracted human fecal DNA samples was 
deemed necessary. A commonly targeted region for detecting microeukaryotes in the gut 
microbiome is the ITS (Internal Transcribed Spacer) region. However, this region is extremely 
truncated in Giardia, with an ITS1 region of 35-40 bp likely among the shortest in all eukaryotes 
[90]. Amplification of a specific gene was therefore the best option for identifying G. intestinalis 
in these samples. 
 
Selection of genes  
 An extensive literature review of publications under the search term “Giardia” in the 
database of the U.S. National Library of Medicine (PubMed) was conducted to determine the 
best genes to target for its detection in fecal samples, as well as potential primer sets to use. From 
this review, five genes of G. intestinalis were found to have been previously successfully used 
for detection: elongation factor 1 alpha (ef1⍺), glutamate dehydrogenase (gdh), triose phosphate 
isomerase (tpi), beta-giardin (bg), and SSU rRNA, with the gdh and tpi genes being especially 
common for discriminating between G. intestinalis assemblages. Feng and Xiao (2011) provide a 
total of ten primer sets targeting four out of these five genes (excluding elongation factor 1 
alpha) that are known to be successful in identifying G. intestinalis. Due to the abundance of 
reference sequences available on the National Center for Biotechnology Information (NCBI) 
GenBank database for the G. intestinalis gdh gene and its previous success in discriminating 
between assemblages, gdh was chosen for this study. 
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PCR Optimization 
Four primer sets targeting the gdh gene of G. intestinalis, according to Feng and Xiao 
(2011), namely, gdh1/gdh2, gdh3/gdh4, GDH1/GDH4, and gdhFi/gdhRi were tested on the G. 
intestinalis positive controls, strains C6 and Be-1, using a polymerase chain reaction (PCR). The 
annealing temperature for each primer set was determined using ThermoFisher’s oligo Tm 
calculator and testing a range of temperatures on the positive controls using a gradient PCR. The 
primer sequences and annealing temperatures are given in Table 1 of this chapter.  
 Out of these, three primer sets best showed amplicons of the expected size: gdh1/gdh2 
(about 750 bp), gdh3/gdh4 (about 530 bp) and gdhFi/gdhRi (about 430 bp), with the region 
amplified by the gdh3/gdh4 primer set located within the same region of the gdh gene amplified 
by the gdh1/gdh2 set. The PCR conditions for each primer set were the same, except for the 
annealing temperatures: the forward and reverse primers were at a final concentration of 0.5 µM, 
dNTPs at a final concentration of 0.2 µM, BSA at a final concentration of 0.1 mg/mL, and 
Phusion HS II enzyme was used in a volume of 0.1 µL per reaction. Three µL of DNA at an 
initial concentration of approximately 5 ng/µL was used. The final volume of the reaction was 20 
µL. The PCR conditions were: an initial denaturation of 98°C for 30 seconds; 35 cycles of 98°C 
for 15 seconds, 60°C (gdh1/gdh2), 63°C (gdh3/gdh4) or 61.5°C (gdhFi/gdhRi) for 30 seconds, 
and 72°C for 1 minute, followed by 72°C for 7 minutes for a final extension. A gel extraction 
and purification of the bands of the expected size was performed following the Qiagen QIAquick 
Gel Extraction Kit protocol. The purified products were provided to the Biology Core Molecular 
Laboratory at the University of Oklahoma for Sanger sequencing in both primer directions to 
verify that the expected regions of the G. intestinalis genome were amplified by each primer set. 
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Primer Set Sequences (5’-3’) Optimal 
Annealing 
Temperature 
gdh1/gdh2 gdh1: TTCCGTRTYCAGTACAACTC 
gdh2: ACCTCGTTCTGRGTGGCGCA 
 
60°C 
gdh3/gdh4 gdh3: ATGACYGAGCTYCAGAGGCACGT 
gdh4: GTGGCGCARGGCATGATGCA 
 
63°C 
GDH1/GDH4 GDH1: ATCTTCGAGAGGATGCTTGAG 
GDH4: AGTACGCGACGCTGGGATACT 
 
62°C 
gdhFi/gdhRi gdhFi: CAGTACAACTCYGCTCTCGG 
gdhRi: GTTRTCCTTGCACATCTCC 
 
61.5°C 
gdh1I/gdh2I gdh1I: GGATGGCTGCGAGAAGGCTAGATTCCGTRTYCAGTACAACTC 
gdh2I: AAGTCTGCACACGAGAAGGCACCTCGTTCTGAGTGGCGCA 
 
62°C 
gdh3I/gdh4I gdh3I: GGATGGCTGCGAGAAGGCTAGAATGACYGAGCTYCAGAGGCACGT 
gdh4I: AAGTCTGCACACGAGAAGGCGTGGCGCARGGCATGATGCA 
 
66°C 
Table 1. Primer sets used in this study targeting the gdh gene of G. intestinalis 
 
The Sanger sequencing data were analyzed using Geneious Prime 11.1.5 
(http://www.geneious.com). The consensus sequences for the three amplicons were queried 
against the NCBI nt database in a Basic Local Alignment Search Tool (BLAST) search [91]. The 
sequences showed a match for the G. intestinalis gdh gene, confirming that the primer sets 
worked. Analysis using Geneious Prime showed that the consensus between the forward and 
reverse primer was slightly better for the gdh1/gdh2 primer set. Since the gdh1/gdh2 primer set 
amplified a region of 750bp (much longer than the regions amplified by gdhFi/gdhRi and 
gdh3/gdh4), the gdh1/gdh2 primer set was chosen for screening the human samples. 
 
Screening of SM samples 
Preliminary testing of eight SM DNA extracts was performed using the gdh1/gdh2 primer 
set and the PCR conditions described above. Amplicons were visualized using gel 
electrophoresis on a 1.5% agarose gel. Visualization of a band of approximately 750 bp 
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suggested that all eight samples contained G. intestinalis. Following this, the remaining SM 
DNA extracts (N = 11) were tested using the same PCR conditions.  
Due to the presence of non-specific bands in most samples, the three SM samples (SM2, 
SM23, and SM29) showing bright and most distinct 750 bp bands were extracted and purified 
using the Qiagen QIAquick Gel Extraction Kit. Subsequently, a PCR was performed using the 
gdh1/gdh2 primer set and the purified SM2, SM23, and SM29 amplicons as the template DNA. 
Visualization of the products of this second round of amplification showed a reduction in the 
amounts of non-specific bands. Gel extraction was performed for the bands at a size of 750 bp, 
followed by purification and Sanger sequencing. This process of double-amplification followed 
by Sanger sequencing was repeated for other SM samples (total N = 16); however, ultimately, 
only four samples (SM2, SM23, SM29, and SM43) yielded usable sequences. The sequences 
from the remaining samples were deemed unusable, due to the many ambiguities and 
interference from non-specific DNA. A BLAST search was used to determine the best hit for the 
consensus sequences. Only one sequence, from sample SM23, showed G. intestinalis as the best 
and unambiguous hit.  
Overall, there were difficulties in obtaining high-quality, specific amplicons from the SM 
samples, resulting in ambiguous sequence data using Sanger sequencing. Thus, we decided to 
adopt a hybrid-sequencing approach using a targeted amplification of the G. intestinalis gdh gene 
and next-generation sequencing (NGS) using Illumina technology. We designed this approach 
such that we could potentially sequence not just the targeted G. intestinalis gdh amplicon, but 
also all non-specific products to determine which other species were being amplified by the 
primer sets. This approach would be useful for a holistic understanding of the gut microbiomes 
of these individuals, as well as for understanding cohabitation of G. intestinalis and other 
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microorganisms. Furthermore, determining what other species are amplified by these primer sets 
would also inform us about further improvements for primer design. 
 
 
Hybrid approach 
 We added Illumina-compatible P5/P7 adapters to the gdh1/gdh2 and gdh3/gdh4 primers, 
such that the primers would amplify the gdh gene as well as provide an attachment site for 
Illumina indexing adapters. These new primers were designated as gdh1I/gdh2I and gdh3I/gdh4I 
(Table 1) and a PCR optimization was performed using G. intestinalis C6 DNA as a positive 
control. The expected lengths of the amplified regions of the gdh gene were about 770 bp for 
gdh1I/gdh2I and about 550 bp for gdh3I/gdh4I. The PCR conditions remained the same as 
previously described with a few alterations: the forward and reverse primers were at a final 
concentration of 0.5 µM, dNTPs at a final concentration of 0.2 µM, and BSA at a final 
concentration of 0.1 mg/mL. Phusion HS II enzyme was used in a volume of 0.1 µL per reaction. 
One µL of DNA at an initial concentration of approximately 5 ng/µL was used. The final volume 
of the reaction was 20 µL. The PCR conditions were: an initial denaturation of 98°C for 30 
seconds; 35 cycles of 98°C for 15 seconds, 62°C (gdh1I/gdh2I) or 66°C (gdh3I/gdh4I) for 30 
seconds, and 72°C for 1 minute, followed by 72°C for 7 minutes for a final extension. 
 
Screening of SM samples 
 A quantitative PCR (qPCR) was performed to identify the appropriate cycle number for 
amplification. The FastStart Essential DNA Green MasterMix and the gdh3I/gdh4I primers were 
used to test the SM samples, the G. intestinalis C6 DNA (positive control), and water (non-
template control, NTC). The qPCR conditions were as follows: 95°C for 10 minutes for the 
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initial denaturation and 50 cycles of 95°C for 10 seconds, 66°C for 20 seconds, and 72°C for 30 
seconds. Most samples amplified between 35 to 50 cycles, suggesting that if the targeted G. 
intestinalis gdh amplicon was present, it was likely at very low amounts. 
Following these results, the SM samples and the positive control were amplified using the 
gdh3I/gdh4I primers and 50 cycles (annealing temperature 66°C and all other conditions the 
same as previously). The amplicons were visualized using gel electrophoresis, and purified using 
a 1.8X bead cleanup using the SeraMag Magnetic SpeedBeads [92] to eliminate all bands shorter 
than 150 bp. After the SpeedBeads were added to each PCR product, the bead cleanup protocol, 
briefly, was as follows: incubation at room temperature for 5 minutes, placing on a magnet for 5 
minutes, removing the supernatant, two washes on the magnet with 150 µL of 80% ethanol, 
drying for 4 minutes, resuspending in 20 µL of water, followed by another 5-minute incubation 
and removal of the supernatant. These purified products were then used as the template DNA for 
an indexing PCR. 
In the indexing PCR, each sample was tagged with Illumina-compatible sequencing 
adapters containing unique indices. The conditions were as follows: the i5 and i7 indices were at 
a final concentration of 0.5 µM, dNTPs at a final concentration of 0.2 µM, and BSA at a final 
concentration of 0.125 mg/mL. Phusion HS II enzyme was used in a volume of 0.2 µL per 
reaction. Four µL of the template DNA and one µL of each unique index were used. The final 
volume of each reaction was 20 µL. The indexing PCR conditions were: an initial denaturation 
of 98°C for 30 seconds; 30 cycles of 98°C for 15 seconds, 60°C for 30 seconds, and 72°C for 45 
seconds, followed by 72°C for 5 minutes for a final extension. This amplification was performed 
over up to five replicates per sample. The replicates of each sample were combined and purified 
using the 1.8X SpeedBead cleanup. 
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Screening of TM samples 
In addition to the 19 SM samples, Burkina Faso (TM) samples were also amplified using 
the hybrid approach. All 46 TM samples were screened using the gdh1I/gdh2I and gdh3I/gdh4I 
primer sets; the amplification with the gdh1I/gdh2I primer set resulted in less non-specific 
amplification. This was in contrast to the SM samples, for which the gdh3I/gdh4I primer set 
showed less non-specific amplification. A subset of 25 TM samples that showed bright bands at 
the desired length of about 770 bp were chosen for indexing (this study was limited by only 48 
unique indices being available for a single Illumina sequencing run). These 25 TM samples 
which had been amplified using gdh1I/gdh2I primers, were purified, indexed, and purified as 
described for the SM samples. This resulted in a final number of 45 samples (SM=19, TM=25, 
and G. intestinalis C6 positive control) which were included on the Illumina MiSeq sequencing 
run.  
The remaining 19 TM samples, which were not indexed for sequencing using the 
Illumina MiSeq, were instead sequenced using the gdh1I/gdh2I primers and Sanger sequencing. 
Following the initial PCR using gdh1I/gdh2I primer set and gel electrophoresis, all samples 
showed a band of about 770 bp. All samples underwent a gel extraction and purification 
following the Qiagen QIAquick Gel Extraction Kit protocol. To increase the final DNA 
concentrations of the samples after the purification process, two replicates of each sample were 
included. Ultimately, 12 out of these 19 samples were Sanger-sequenced in both primer 
directions at the Biology Core Molecular Laboratory at the University of Oklahoma. 
 
Illumina MiSeq sequencing 
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All indexed samples (N=45) were quantified using the Kapa Library Quantification Kit 
and following the kit protocol. Kapa Library Standards and NTC were included. Samples were 
also analyzed using either a Fragment Analyzer or TapeStation system to acquire their DNA 
concentration (ng/µL), average bp sizes, and molarity (nmol/L). For the Fragment Analzyer, the 
High Sensitivity Small Fragment Kit was used, whereas the D1000 assay was used for the 
TapeStation. 
All samples were pooled in equimolar ratios into two pools: one for fragments ranging 
between 150 bp and 500 bp (which should comprise all non-specific amplicons), and one for 
fragments ranging from 501 bp to 1000 bp (which should include the desired fragments of the G. 
intestinalis gdh gene). The average bp sizes and molarity (nmol/L) for both the 151-500 bp range 
and 501-1000 bp range, along with the concentration (ng/µL) and target nanomole (nM) for each 
sample were used to calculate the amount of each sample to add to each pool.  
To purify the pools and eliminate fragments outside of the desired range, each pool was 
run on a PippinPrep. A 2% agarose cassette was used for the 151-500 bp pool (pool 1) and a 
1.5% agarose cassette for the 501-1000 bp pool (pool 2). After the runs, both eluted pools were 
quantified using the D1000 High Sensitivity assay on the TapeStation as well as a Kapa Library 
Quantification qPCR assay. For the latter, dilutions of each pool were assessed in triplicate to 
accurately quantify the molarity of each pool prior to sequencing. The average molarity across 
all dilutions for each pool was calculated to be 6.896 nM for pool 1 and 6.259 nM for pool 2. 
Each pool was diluted to 4 nM. The final sequencing reaction comprised 15% pool 1 and 85% 
pool 2 and was loaded at a final concentration of 12 pM. The run also included a 15% PhiX 
spike-in to increase diversity. The sequencing was conducted using 2 x 250 bp V2 chemistry on 
the Illumina MiSeq machine at the Consolidated Core Laboratory at the University of Oklahoma.    
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Data analysis 
 The Illumina sequence reads were demultiplexed using the bcl2fastq software. The 
numbers of raw reads across all samples ranged from 317 to 2,249,066. The reads were trimmed 
using AdapterRemoval v2 [93] using the following parameters: --trimns, --trimqualities, --
minquality 30, --maxns 0. Paired reads were merged. Analysis-ready reads (merged as well as 
unmerged trimmed reads) were then queried in a BLASTX search against the NCBI non-
redunant (nr) database using DIAMOND, with default parameters [94]. The analysis-ready reads 
were also mapped to G. intestinalis reference genome using bowtie2 with default parameters and 
the –no-unal option to discard unmapped reads [95]. 
 Phylogenetic analyses were performed using the sequence obtained from Sanger 
sequencing of the SM23 sample and 33 published G. intestinalis isolates belonging to different 
assemblages acquired from NCBI GenBank. Two outgroups were included for reference and to 
more accurately resolve the relationships among the G. intestinalis assemblages: Giardia ardeae 
(another species of Giardia) and Spironucleus vortens (another organism of the taxonomic 
family Hexamitidae). Using MEGA version 7 [96], the SM23 sequence and all 33 published 
sequences were aligned with ClustalW and phylogenetic trees were built using the Neighbor-
Joining (NJ) method and the Kimura two-parameter model. The NJ method and Kimura two-
parameter model are consistent with previous phylogenetic analyses of Giardia intestinalis 
assemblage data that produced well supported topologies [11]. 
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CHAPTER 4 
RESULTS AND DISCUSSION 
 
Results 
Molecular detection of Giardia has frequently used a taxonomically diagnostic gene 
approach, which we replicated by targeting the glutamate dehydrogenase (gdh) gene. However, 
we noted that a targeted PCR-based approach produced non-specific amplicons, despite the use 
of previously published primers that were supposedly specific for the G. intestinalis gdh gene. 
We then adopted a hybrid-sequencing approach using targeted amplification and next-generation 
sequencing (NGS) with Illumina technology. The goal of our hybrid approach was to obtain high 
quality sequences of the G. intestinalis gdh gene from Matses (SM) and Burkina Faso (TM) 
samples as well as to sequence non-specific products to determine which other species were 
being amplified by our primer sets. Ultimately, we aimed to assess the G. intestinalis assemblage 
diversity in these traditional populations. 
Using the hybrid approach, 45 samples were sequenced on the Illumina MiSeq. Since the 
G. intestinalis gdh amplicons were expected to be greater than 500 bp in length (gdh1I/gdh2I = 
770 bp, gdh3I/gdh4I = 550 bp), we expected that paired reads covering these amplicons would 
not overlap and would not be merged. As such, any merged reads in our data could be attributed 
to either our non-specific amplicons of smaller fragment lengths or adapter heteroduplexes 
formed during the amplification process. However, across all samples, the proportion of quality-
filtered, merged reads ranged from 60-95% (Supplemental Table 1), suggesting that our target G. 
intestinalis gdh amplicons were either not sequenced or were covered by a very low proportion 
of reads. Mapping of the trimmed reads (merged and unmerged) to both the G. intestinalis 
genome as well as the G. intestinalis gdh gene showed that a negligible number of unique reads 
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mapped to these targets across all samples, including the G. intestinalis C6 positive control 
(Supplemental Table 1). The lack of reads mapping to the G. intestinalis genome for the positive 
control suggests that our hybrid sequencing approach did not work. A further analysis of the 
trimmed (merged and unmerged) reads employing a BLASTX search conducted using 
DIAMOND showed that the reads were attributed to various bacterial species, including 
commonly found gut microbes such as Prevotella and Firmicutes. None of the samples, 
including the positive control, comprised any reads attributed to G. intestinalis. Therefore, no 
further analyses were conducted on the Illumina data.  
Out of the 19 SM samples, we were able to obtain four usable sequences using the 
targeted amplification and Sanger sequencing (for samples SM2, SM23, SM29, and SM43). The 
success rate was higher for the TM samples, with 12 out of 19 samples producing usable 
sequences. However, when the consensus sequences for these amplicons were queried against 
the NCBI nt database using a BLAST search, only one (sample SM23) showed G. intestinalis as 
the best and unambiguous hit. Other samples showed different bacterial species as the best hit. 
For example, Ruminococcus champanellensis NADP-dependent gdh gene was the best hit for 
SM2, whereas G. intestinalis was not in the results. The best hit for SM29 was Flavonifractor 
plautii NADP-specific gdhA gene; however G. intestinalis gdh gene of assemblage F was the 
14th hit and nearly all of the rest of the 100 hits were G. intestinalis. The best hit for SM43 was 
the Bifidobacterium adolescentis gdh gene. The top 50 hits for SM43 were almost exclusively 
Bifidobacterium species, but several hits lower on the scale were the G. intestinalis gdh gene. 
We further analyzed the SM and TM Sanger sequence data in Geneious Prime. The SM 
sequences have some noticeable differences between them - all except SM43 contain many 
ambiguities and, when aligned, have only 52.2% identical sites. In contrast, the TM sequences 
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are nearly identical, except two sequences (TM5-2 and TM12-4) that are not as clean as the 
others. With TM5-2 and TM12-4 excluded, an alignment of the remaining TM sequences shows 
90.8% identical sites. The best BLAST hit for all TM sequences was the Flavonifractor plautii 
gdhA gene, with no G. intestinalis hits. However, the TM sequences show 65.6% identical sites 
and 92.5% pairwise identity with the G. intestinalis C6 control. Individually, the identical sites 
and pairwise identity of each TM sequence with C6 range from 67% to 71%. 
Since SM23 was the only sequence to unambiguously register as G. intestinalis in the 
BLAST results, further analyses primarily only involved sample SM23. This sequence had 
numerous ambiguous sites; thus, we attempted to determine if two assemblages of G. intestinalis 
were coexisting in the same individual or if G. intestinalis was co-occurring with another 
identifiable organism. Additionally, we aimed to place this sample in a phylogeny of G. 
intestinalis assemblages by building a tree that included the SM23 sequence and 33 published G. 
intestinalis isolates belonging to different assemblages acquired from NCBI GenBank.  
To address these questions, five versions of the SM23 sequence were created by editing 
the ambiguity codes in different ways. The first sequence was the original with zero ambiguity 
code alterations. To confirm the BLAST designation of assemblage C, phylogenetic analyses 
were conducted in MEGA involving the SM23 sequence and 33 published G. intestinalis isolates 
(Figure 1). Multiple reference sequences of each assemblage were included, as well as the two 
outgroups previously described: Giardia ardeae and Spironucleus vortens. SM23 did not form a  
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Figure 1. Neighbor-Joining tree with the original SM23 sequence. The Kimura 2-parameter 
model and 500 bootstrap replicates were used. The scale indicates substitutions per site. 
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clade with G. intestinalis assemblage C reference sequences. Rather, SM23 branched off 
independently from all published G. intestinalis strains, but with a relatively weak bootstrap 
support of 48. This finding calls into question the true assemblage designation of our sequence. 
In the second and third versions, the ambiguity codes of the SM23 sequence were 
subsequently edited to firstly, examine the effect that assuming assemblage C had on the 
phylogenetic placement of this sequence and secondly, determine if a second assemblage of G. 
intestinalis was co-occurring in this individual. In the second version, all ambiguous sites of 
SM23 were individually examined and changed to a nucleotide that matched the assemblage C 
reference sequences, if possible. If the base call(s) suggested by the ambiguity code did not 
match the reference base in assemblage C, but matched that in another G. intestinalis 
assemblage, the position was edited to match the other assemblage. If neither option matched the 
base present in any assemblage, the ambiguity code was replaced with an N. The resulting SM23 
sequence was used to build the NJ tree. In this tree, SM23 formed a clade with the G. intestinalis 
assemblage C reference sequences, but with low bootstrap support of 38 (Figure 2). When this 
edited SM23 sequence was queried against the NCBI nt database using a BLAST search, G. 
intestinalis was no longer the best hit; the best hit was Methanomassiliicoccaceae archaeon, a 
common methanogen. However, the G. intestinalis gdh gene of assemblage C was the 7th hit, and 
every subsequent hit after was also G. intestinalis. Clearly, the assumption of assemblage C does 
affect the phylogenetic placement of our amplicon and adds credence to the original BLAST 
designation. However, we cannot make a valid conclusion from an assumption, and the low 
bootstrap support and incongruous BLAST results of the version 2 sequence reflect assemblage 
uncertainty of the SM23 isolate. 
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Figure 2. Neighbor-Joining tree with the SM23 sequence tailored to assemblage C. The Kimura 
2-parameter model and 500 bootstrap replicates were used. The scale indicates substitutions per 
site. 
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Out of the total 59 ambiguous sites that were edited in version two, 30 were changed to a 
nucleotide that matched all G. intestinalis reference sequences. In the third sequence version, any 
ambiguous sites that did not match all assemblages were changed to the alternate nucleotide from 
the previous edit, according to the ambiguity code and provided it still matched one or more G. 
intestinalis assemblages. All “N”s, which were representative of ambiguities that did not match 
any assemblage, were kept as an “N”. In the phylogenetic analysis that followed these alterations 
to the sequence, SM23 formed a clade with assemblage H sequences, with bootstrap support of 
46 (Figure 3). BLAST results were essentially identical to those of version two of SM23, with 
Methanomassiliicoccaceae archaeon as the top hit and G. intestinalis assemblage C the 7th. 
Considering the low bootstrap value of the version three phylogeny, the fact that only 14 of the 
59 ambiguities in the SM23 sequence were a difference between two G. intestinalis assemblages, 
and the identical BLAST results between SM23 sequence versions two and three, it is unlikely 
there is a co-occurrence of assemblages in our amplicon. 
In the fourth version, to assess whether the ambiguities reflected the amplification of 
another organism’s DNA in addition to G. intestinalis, all ambiguous sites in SM23 of which one 
nucleotide previously matched all G. intestinalis assemblages were changed to the alternative 
nucleotide. Additionally, any positions that had been deemed “N” were changed to one of the 
possible nucleotides according to the original sequence’s ambiguity code. BLAST results were 
fairly consistent with the results from the two previous edits that had tailored SM23 to either G. 
intestinalis assemblage C or an alternative assemblage: Methanomassiliicoccaceae archaeon was 
again the best hit, with G. intestinalis the 6th hit and every hit after that. Since M. archaeon was 
the best hit in BLAST after all three edits to the SM23 sequence, it is possible we amplified the 
DNA from this archaeal species in addition to the gdh gene of G. intestinalis. 
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Figure 3. Neighbor-Joining tree with version three of the SM23 sequence. The Kimura 2-
parameter model and 500 bootstrap replicates were used. The scale indicates substitutions per 
site. 
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Figure 4. Neighbor-Joining tree with version five of the SM23 sequence. The Kimura 2-
parameter model and 500 bootstrap replicates were used. The scale indicates substitutions per 
site. 
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The final, fifth version of the SM23 sequence aimed to eliminate any bias by changing all 
ambiguous sites to “N”. The phylogenetic relationship of SM23 to all G. intestinalis reference 
strains was then re-assessed following a similar tree building method as used previously. As with 
the analysis of the original SM23 sequence, this NJ phylogenetic analysis placed SM23 outside 
of all assemblages, with bootstrap support of 89 (Figure 4). In discordance with the phylogeny, 
BLAST identified this version of SM23 once again as assemblage C, with every BLAST hit as 
G. intestinalis gdh gene. 
It is apparent that when ambiguities in the SM23 sequence are kept—either by the 
original ambiguity codes or in the form of “N”—BLAST recognizes the sequence better as G. 
intestinalis generally, and assemblage C particularly, compared to when it is tailored to match 
one or more of the G. intestinalis assemblages. In contrast, phylogenetically the ambiguities 
result in SM23 being placed outside of known G. intestinalis assemblages. 
A further analysis of the SM23 sequence in excel determined that after position 278, the 
number of ambiguity sites significantly increases, suggesting less reliable data. When truncated, 
the 278 bp SM23 sequence is still identified as G. intestinalis assemblage C in BLAST. 
However, a NJ phylogenetic analysis places our sequence in a clade with assemblage H 
(bootstrap=51) (Figure 5). While removing the ambiguous sites after position 278 does not 
impact the BLAST designation of our amplicon, it does affect the phylogeny, placing the isolate 
in a clade with published G. intestinalis assemblages. This further confirms that the SM23 
amplicon is G. intestinalis; however, a relatively low bootstrap support value precludes any 
confident conclusion about its true assemblage. 
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Figure 5. Neighbor-Joining tree with the truncated, 278 bp SM23 sequence. The Kimura 2-
parameter model and 500 bootstrap replicates were used. The scale indicates substitutions per 
site. 
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Discussion 
 
Methodology 
Our study was greatly challenged by the quality of our data. The hybrid-sequencing 
approach was designed to better explore the non-specific amplifications produced by targeted 
amplification of the glutamate dehydrogenase gene, and to improve the sequence quality of our 
desired amplified gdh regions suspected to be Giardia intestinalis. While the theoretical basis of 
this approach is sound, it was unsuccessful in practice. 
Sanger sequencing is only able to produce one sequence for each sample, making it 
difficult to separate non-specific amplifications from our intended amplicon in the sequence. In 
contrast, next-generation sequencing with the Illumina MiSeq uses a massively parallel 
approach, sequencing millions of fragments simultaneously. Not only will our intended amplicon 
be sequenced, but additionally any other DNA fragments that were amplified in the sample will 
have a separate sequence. Naturally, this improves the sequence quality of our desired gdh region 
by removing the non-specific interference bioinformatically. During sample preparation, each 
sample received unique indices that should have attached to each amplified DNA fragment in the 
sample. These indices enable the pooled sequences to be separated and organized by their unique 
barcodes during the data analysis portion of the MiSeq run, which in turn informs us as to which 
sample each sequence belongs. Ultimately, this process should create a depiction of precisely 
which organisms are present in each of our samples. 
When the hybrid approach was put into practice, it did not produce the intended results. 
The expected G. intestinalis gdh amplicon lengths of greater than 500 bp and our selected read 
length of 2 x 250 should have precluded any overlap of forward and reverse reads during the 
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Illumina MiSeq run. However, the merged reads proportion ranged from 60-95%, indicating that 
the amplicons read were shorter than our targeted amplicons, thus our amplicons were not read. 
Further confirmation was that the C6 G. intestinalis positive control read did not map to the G. 
intestinalis genome, suggesting it was not properly sequenced. Ideally, there should be some 
overlap—about 30-50 bp—of the forward and reverse reads, to ensure the full amplicon is 
sequenced. Yet, when fragments are longer, such as our expected G. intestinalis gdh amplicons, 
the chances of overlap, and therefore complete sequencing, are less. We suggest that in future 
attempts of this approach, a smaller amplicon should be targeted to enable some overlap, but not 
so small such that there is redundancy in the reads. This would require redesigning the primers to 
target a region of the gdh gene of G. intestinalis that is shorter, yet still sufficiently variable 
within the species to enable distinguishing among the assemblages. In addition to this, the 
selected read length for the MiSeq could be adjusted to allow some overlap of the reads. 
The primers we selected for the hybrid approach may not be optimal for reasons other 
than length of the amplified region as well. While the gdh1/gdh2 and gdh3/gdh4 primers are 
listed as “commonly used primers for the species/genotype and subtype differentiation of 
Giardia isolates in animal and human specimens” [11], it is unclear how well they can 
discriminate G. intestinalis from bacteria, archaea, and other microeukaryotes present in the 
human gut. The two primer sets were newly designed by Cacció et al. (2008) to amplify a 
fragment of the G. intestinalis gdh gene through nested PCR [97]. However, the fecal samples of 
that study had first been microscopically screened for Giardia cysts by immunofluorescence, and 
subsequently underwent DNA extraction specifically designed to increase the sensitivity of 
protozoan parasite DNA detection in fecal samples [98]. Thus, presumably the primer sets were 
used to screen DNA extracts that already primarily consisted of G. intestinalis DNA. In contrast, 
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we screened extracts that had captured all DNA present in human fecal samples, including DNA 
from bacteria and archaea, and we had no prior knowledge as to whether the samples contained 
G. intestinalis. 
It may be that the gdh1/gdh2 and gdh3/gdh4 primer sets are optimized for genotyping G. 
intestinalis isolates in order to discriminate assemblages and subassemblages, but are not specific 
enough to distinguish G. intestinalis from other gut microorganisms with homologous genes.  
As described above, these primer sets were designed to amplify G. intestinalis in the absence of 
other microorganisms typically present in the human gut. Thus, they likely do not account for 
recurrent mutations that may have occurred over evolutionary time in that region of the gdh gene 
of other microorganisms, making that region homologous and preventing discrimination of 
Giardia. While we did seek primers that could discriminate among the various assemblages, 
primer sets targeting smaller, more G. intestinalis-specific regions may be more ideal for the 
initial detection of G. intestinalis from fecal extracts using PCR, as well as for NGS as described 
above. The BLAST results from SM29 and SM43 sequence queries included Giardia 
intestinalis, thus it is possible that the microeukaryote is present in these individuals and further 
optimization to our methodology by designing new primers is needed to unambiguously detect it. 
Another issue of our method may lie in the choice of gene. The gdh gene (along with 
SSU rRNA, tpi, ef1⍺, and bg) is among the five most common genes targeted for the 
differentiation of Giardia at the species/assemblage and genotype levels and the identification of 
G. intestinalis genotypes in clinical samples [11]. These loci vary in terms of substitution rates, 
and gdh is in the middle on the conserved to variable range, with a 0.06 substitutions per 
nucleotide rate [99]. While this allows the gdh gene to have broad applications, with a traditional 
PCR-based approach alone it may be too conserved to distinguish G. intestinalis from other 
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common microorganisms in the human gut. According to BLAST, Ruminococcus 
champanellensis, Flavonifractor plautii, and Bifidobacterium adolescentis were the other top 
organisms we amplified in our PCR-based approach, and upon further inquiry into the NCBI 
database, it was the gdh gene specifically being amplified in each organism. Other studies on G. 
intestinalis in traditional populations used a multilocus approach for amplification and 
genotyping of G. intestinalis [59,57,56,34]. Thus, targeting more than one of the five common 
genes listed above may be a way to optimize our method in the future. 
 
Giardia intestinalis in the Matses 
 The resolution of our data confirms the presence of Giardia intestinalis in our hunter-
gatherer population from the Peruvian Amazon. Unambiguously, BLAST results identified the 
amplicon from an asymptomatic, healthy seven-year-old male (SM23) as the glutamate 
dehydrogenase gene of G. intestinalis. However, there is uncertainty surrounding to which 
assemblage the amplicon belongs. Phylogenetic analysis of the original, unedited sequence 
places SM23 outside of known, published G. intestinalis assemblages, as does changing all 
ambiguity codes to “N". Yet, the removal of many ambiguities after position 278 causes SM23 to 
form a clade with assemblage H, and the sequence forms a clade with assemblage H or C when 
the ambiguities are tailored to match G. intestinalis assemblages. In contrast to all but one of 
these phylogenies, BLAST consistently identifies all versions of the SM23 sequence as 
assemblage C. 
 There are two competing explanations for this pattern of uncertainty: our G. intestinalis 
isolate is outside of known assemblages, or homologous genes confounded the data. The first 
possibility relates to research and database biases that have favored urban settings and left gaps 
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in data from much of South America. It is likely from BLAST results and phylogenetically 
informative markers that the SM23 isolate is not assemblage A or B. Yet, the majority (60%) of 
reported G. intestinalis assemblage data worldwide is assemblage A or B [62], which 
significantly limits the number of varied assemblage reference sequences to which our sequence 
can be compared. We currently only know of two studies that found an assemblage of G. 
intestinalis other than A or B in humans in South America, both of which were located in 
metropolitan regions of Brazil. There were 15 cases of assemblage E in a Rio de Janeiro nursery 
[8] and a few cases of assemblage C in the city of Campinas [51]. As the worldwide assemblage 
data from Garcia-R. et al. (2017) showed, the majority of the G. intestinalis data in South 
America comes from Brazil. Thus, there are likely various G. intestinalis assemblages present in 
humans of other parts of South America that have gone unreported. This could be especially true 
for hunter-gatherer and other traditional populations, whose lifestyles and gut microbiomes differ 
significantly from urban and rural industrialized societies that are more frequently studied. 
 A study of the genetic diversity of G. intestinalis obtained from humans in three different 
Brazilian biomes found higher genetic diversity of assemblage B in the Amazon rainforest [100]. 
Considering the bg (beta-giardin) genetic target, 23 previously undescribed assemblage B 
sequences were identified, which were considered new subassemblages of B. Furthermore, 
subassemblage AIII was detected only in the Amazon [100], whereas an extensive study of 
primarily European isolates and about 45% GenBank sequences did not find subassemblage AIII 
in any humans [50]. The Brazilian biome study attributed the higher genetic diversity of 
assemblage B in the Amazon to demographic and socioenvironmental differences between it and 
the other two Brazilian regions, though notably the Amazonian population was of an urban 
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nature [100]. Furthermore, there was considerable genetic diversity of G. intestinalis 
subassemblages in children of a traditional society in the Colombian Amazon [34]. 
 Considering multiple new subassemblages of B and the rare AIII subassemblage were 
recently identified in the Brazilian Amazon, and that there is a great diversity of subassemblages 
in the Colombian Amazon, further G. intestinalis genetic diversity is likely in the Peruvian 
Amazon, especially in traditional populations. Our G. intestinalis isolate from a hunter-gatherer 
society in the Peruvian Amazon was identified as assemblage C when queried against the NCBI 
nucleotide database, but placed outside of known assemblages in the unbiased phylogenetic 
analyses, suggesting it could be a novel subassemblage. This subassemblage could belong to 
assemblage C or H according to the nucleotide options suggested by ambiguity codes, but 
phylogenetic uncertainty precludes a concrete answer. 
 Homologous genes could alternatively be confounding the data, preventing SM23 from 
forming a definitive clade with its true assemblage in the phylogenetic analysis. In the other 
Matses and Burkina Faso samples, we amplified regions of the gdh gene from other organisms 
(namely Ruminococcus champanellensis, Flavonifractor plautii, and Bifidobacterium 
adolescentis). Additionally, when ambiguities in the SM23 sequence were changed to a specific 
nucleotide, the top BLAST hit was consistently Methanomassiliicoccaceae archaeon. Thus, it is 
plausible that DNA from the gdh gene of M. archaeon is present in our amplicon and precluding 
its full taxonomic resolution. 
 
Conclusions and Future Directions 
The hybrid approach of traditional PCR-based amplification and next-generation 
sequencing has potential to successfully capture G. intestinalis genetic diversity from human 
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fecal samples. We confirmed the presence of Giardia intestinalis in the Matses population, a 
hunter-gatherer community from the Peruvian Amazon. However, the quality of our data, as well 
as probable database bias, limited our ability to confidently define the assemblage or confirm the 
presence of G. intestinalis in other samples. Given the precedence in the literature for both 
zoonotic transmission of assemblages C, D, E, and F, and higher genetic diversity of G. 
intestinalis in the Amazon, it is reasonable to believe our SM23 isolate from the Matses 
community could be a novel subassemblage of G. intestinalis, possibly of assemblage C. 
Further optimization of the hybrid approach beyond the scope of this study is necessary 
to better detect and genotype G. intestinalis in the Matses and Burkina Faso communities. In 
particular, primers should be redesigned to target a shorter, more Giardia-specific region of the 
gdh gene, or target a different gene entirely. Additionally, a multilocus genotyping approach may 
produce more robust results. To our knowledge, this was the first study to assess the genetic 
diversity of G. intestinalis in a hunter-gatherer population of Peru. More research should be 
conducted in traditional communities of Peru specifically and South America in general to fill 
the gap in reported G. intestinalis assemblages in humans. It is likely that hunter-gatherer 
populations may harbor a greater diversity of assemblages in a commensal state, and more 
insight into this possibility will reveal much about the true nature of Giardia intestinalis in the 
human gut microbiome. 
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SUPPLEMENTAL DATA 
 
 
 
Supplemental Table 1. MiSeq Results 
 
Sample Raw Reads 
Analysis-
ready reads 
% of reads 
merged 
Number of reads 
mapped to G. 
intestinalis 
genome 
Number of 
unique reads 
mapped to G. 
intestinalis 
genome 
Number of reads 
mapping to the 
G. intestinalis 
gdh gene 
C6 7379 6588 89.29 0 0 0 
SM10 28645 19434 67.85 5 3 0 
SM11 376053 282703 75.18 31 12 0 
SM18 86970 75167 86.43 5 3 0 
SM1 250225 226412 90.49 5 5 0 
SM20 115443 104711 90.71 15 7 0 
SM23 220281 182823 83 57 4 0 
SM28 103404 66586 64.4 14 4 0 
SM29 94655 58710 62.03 6 4 0 
SM2 29538 26959 91.27 1 1 0 
SM31 246140 220980 89.78 2 1 0 
SM32 1056431 822859 77.9 99 20 0 
SM33 71819 64051 89.19 8 3 0 
SM37 25497 23145 90.78 0 0 0 
SM39 78685 70299 89.35 2 2 0 
SM3 112756 81863 72.61 3 2 0 
SM40 222122 199184 89.68 16 8 0 
SM41 91813 80588 87.78 4 2 0 
SM43 14232 12985 91.24 1 1 0 
SM44 41111 37199 90.49 3 2 0 
TM10-2 722695 650411 90 3 2 0 
TM10-3 2054572 1899661 92.47 0 0 0 
TM10-4 1752938 1633473 93.19 2 1 0 
TM11-1 2249066 2127916 94.62 7 5 0 
TM1-2 216730 204294 94.27 0 0 0 
TM1-3 23565 18172 77.12 0 0 0 
TM1-4 84776 73461 86.66 0 0 0 
TM2-2 1098615 1028203 93.6 3 3 0 
TM2-3 413915 345877 83.57 90 19 0 
TM2-4 180877 172556 95.4 0 0 0 
TM4-3 72663 59902 82.44 0 0 0 
TM4-4 30956 28355 91.6 0 0 0 
  70 
TM5-1 8878 8095 91.19 3 2 0 
TM5-3 36690 26939 73.43 8 1 0 
TM6-1 160813 104339 64.89 0 0 0 
TM6-2 631639 483100 76.49 113 3 0 
TM6-3 793690 722301 91.01 3 3 0 
TM7-2 345827 300960 87.03 1 1 0 
TM7-4 317 290 91.49 0 0 0 
TM8-2 1568 1490 95.03 0 0 0 
TM8-4 57479 51260 89.19 0 0 0 
TM9-1 55682 47496 85.3 0 0 0 
TM9-2 72375 59609 82.37 0 0 0 
TM9-3 20578 18469 89.76 8 6 0 
TM9-4 1024372 921514 89.96 3 1 0 
 
